Evidence map›Paper›PMID 41958625›Full record

ArticleJMA journal2026

Oral Squamous Cell Carcinoma Incidence in Japan Based on National Cancer Registry Data 2016-2019.

Shihoko Koyama, Toshitaka Morishima, Kayo Nakata, Nao Nishimura, Miki Ishibashi, Isao Miyashiro

Abstract read
In one paragraph

Article in JMA journal, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Shihoko KoyamaCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Toshitaka MorishimaCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Kayo NakataCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.
Nao NishimuraDepartment of Oral and Maxillofacial Surgery, Japanese Red Cross Society Kyoto Daini Hospital, Kyoto, Japan.
Miki IshibashiDepartment of Cancer Oral Care, Dentistry and Oral Maxillofacial Surgery, Osaka International Cancer Institute, Osaka, Japan.
Isao MiyashiroCancer Control Center, Osaka International Cancer Institute, Osaka, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Introduction: No comprehensive national profiles of oral squamous cell carcinoma (OSCC) have been established in Japan. We set out to describe the profiles of OSCC cases, including demographic characteristics, regional disparities, and survival time on a national basis, using a population-based dataset in Japan. Methods: Using the national cancer registry (NCR) of Japan, we aggregated data on cases of OSCC from 2016 to 2019 that were classified according to the diagnostic criteria specified in the Japanese oral cancer guidelines. We calculated annual, detailed site-specific distributions by sex and age-standardized incidence rates for each year. The standardized incidence ratios by prefecture were computed using 2016 to 2019 data. One-year overall survival was estimated using the Kaplan-Meier method. Univariate and multivariate analyses were conducted using the Cox proportional hazards model. Results: Between 2016 and 2019, data were obtained on 30,537 OSCC incidence cases. In the most recent year, 2019, 57.0% of patients were men, and the mean age was 70.3 years. Among the specific OSCC sites, the tongue was the most common, accounting for more than half the cases. Over half the cancers were localized at the time of diagnosis. The age-standardized incidence rate in 2019 was 5.12 per 100,000 population. The standardized incidence ratios of OSCC among different prefectures ranged from 0.77 (Gifu Prefecture) to 1.37 (Miyagi Prefecture). The one-year survival rate for all OSCC cases diagnosed between 2016 and 2019 was 83.5%. Cox proportional hazards model analysis, adjusted for all covariates, revealed that women had a significantly lower risk of death within one year than men (hazard ratio = 0.81, 95% confidence interval = 0.76-0.87). Conclusions: Our study provides an overview of OSCC epidemiology in Japan using the NCR population-based dataset.

Indexed as

incidencelip and oral cavity cancersquamous cell carcinoma

Identifiers

PMID41958625
PMCPMC13058742

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.